Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection

1. Provencio, M.
2. Majem, M.
3. Guirado, M.
4. Massuti, B.
5. de las Peñas, R.
6. Ortega, A.L.
7. Dómine, M.
8. Marsé, R.
9. Sala, M.Á.
10. Paredes, A.
11. Morán, T.
12. Vázquez, S.
13. Coves, J.
14. Larriba, J.L.G.
15. Sánchez, J.M.
16. Vicente, D.
17. Farré, N.
18. Fornos, L.F.
19. Zapata, I.
20. Franco, F.
21. Serna-Blasco, R.
22. Romero, A.
23. Isla, D.